SC
DXCM icon

Stance Capital’s DexCom DXCM Stock Holding History

Stance Capital’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.74K Sell
100
-599
-86% -$39.9K ﹤0.01% 294
2026
Q1 		$43.9K Buy
+699
New +$48.7K 0.02% 153
2025
Q4 		– Sell
-666
Closed -$44.8K – 179
2025
Q3 		$44.8K Buy
+666
New +$52.7K 0.02% 187

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Stance Capital's DXCM Position: Q2 2026 in Review

Stance Capital reduced its DexCom (DXCM) stake by 86% in Q2 2026, selling an estimated $39.9K and leaving 100 shares worth $6.74K. The position accounts for ﹤0.01% of the portfolio, ranked #294.

Stance Capital first reported a position in DXCM in Q3 2025 and has held it in 3 quarters since. The position peaked at $44.8K in Q3 2025. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Stance Capital held 100 shares of DexCom worth $6.74K as of Q2 2026.
  • Stance Capital sold 599 DexCom shares in Q2 2026, an estimated $39.9K.
  • DexCom made up ﹤0.01% of Stance Capital's portfolio in Q2 2026, its #294 holding.
  • Stance Capital first reported a position in DexCom in Q3 2025 and has held it in 3 quarters since.
  • Stance Capital's DexCom position peaked at $44.8K in Q3 2025.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Stance Capital's 13F filing for Q2 2026, filed 14 Aug 2026.